世界の B 型肝炎ウイルス (HBV) ワクチン市場は、2021 年に 22 億 3000 万ドルと評価され、2027 年には 30 億 4000 万ドルに成長すると予測されます。 B 型肝炎ウイルス (HBV) は、肝臓の感染症を引き起こすウイルスです。感染者の血液や体液に触れることで感染します。これは、性的接触、針やその他の薬物注射器具の共有、または医療環境での血液や体液への曝露によって発生する可能性があります。また、感染した母親から出産時に子供に感染することもあります。 B 型肝炎は、肝障害、肝硬変、肝がんなどの長期的な健康問題を引き起こす深刻な疾患です。
B型肝炎ワクチンは、B型肝炎ウイルスによる感染を予防する効果的な方法です。ワクチン接種は、B 型肝炎ウイルス (HBV) 予防の中核要素であり、2030 年までに B 型肝炎を根絶するという世界保健機関 (WHO) の取り組みにおける重要な介入です。1981 年に最初の B 型肝炎ワクチンが承認されて以来、B 型肝炎ワクチンには大きな進歩がありました。さらに、ワクチンの推奨事項は数十年にわたって進化し、60 歳未満のすべての人に対する B 型肝炎の予防接種の推奨に至りました。市場は、2022 年から 2027 年の予測期間中 5.28% の CAGR で成長すると予想されます。
目次
1. Executive Summary
2. Introduction
2.1 Hepatitis B Virus Vaccine: An Overview
2.1.1 Common Symptoms of Hepatitis B Virus
2.1.2 Chronology & Type of Hepatitis B Vaccines Licensed for Use in the US
2.1.3 Indications for Hepatitis B Vaccination
2.2 Hepatitis B Virus Vaccine Segmentation: An Overview
2.2.1 Hepatitis B Virus Vaccine Segmentation
3. Global Market Analysis
3.1 Global Hepatitis B Virus (HBV) Vaccine Market: An Analysis
3.1.1 Global Hepatitis B Virus (HBV) Vaccine Market: An Overview
3.1.2 Global Hepatitis B Virus (HBV) Vaccine Market by Value
3.1.3 Global Hepatitis B Virus (HBV) Vaccine Market by End User (Adult & Pediatric)
3.1.4 Global Hepatitis B Virus (HBV) Vaccine Market by Region (The US, China, EU+UK, Japan, and Rest of the World (ROW))
3.2 Global Hepatitis B Virus (HBV) Vaccine Market: End User Analysis
3.2.1 Global Hepatitis B Virus Vaccine Market by End User: An Overview
3.2.2 Global Adult Hepatitis B Virus Vaccine Market by Value
3.2.3 Global Adult Hepatitis B Virus Vaccine Market by Composition (Mono Vaccine & Combination Vaccine)
3.2.4 Global Pediatric Hepatitis B Virus Vaccine Market by Value
3.3 Global Adult Hepatitis B Virus (HBV) Vaccine Market: Composition Analysis
3.3.1 Global Adult Hepatitis B Virus Vaccine Market by Composition: An Overview
3.3.2 Global Adult Mono Hepatitis B Virus (HBV) Vaccine Market by Value
3.3.3 Global Adult Combination Hepatitis B Virus (HBV) Vaccine Market by Value
4. Regional Market Analysis
4.1 The US Hepatitis B Virus (HBV) Vaccine Market: An Analysis
4.1.1 The US Hepatitis B Virus (HBV) Vaccine Market: An Overview
4.1.2 The US Hepatitis B Virus (HBV) Vaccine Market by Value
4.1.3 The US Hepatitis B Virus (HBV) Vaccine Market by Eligible Adults
4.1.4 The US Hepatitis B Virus (HBV) Vaccine Market by Number of Patients Who Receive HBV Vaccine
4.2 China Hepatitis B Virus (HBV) Vaccine Market: An Analysis
4.2.1 China Hepatitis B Virus (HBV) Vaccine Market: An Overview
4.2.2 China Hepatitis B Virus (HBV) Vaccine Market by Value
4.2.3 China Hepatitis B Virus Vaccine Market by Composition (CHO, Saccharomyces Cerevisiae and Hansenula Polymorpha)
4.2.4 China CHO Hepatitis B Virus (HBV) Vaccine Market by Value
4.2.5 China Hansenula Polymorpha Hepatitis B Virus (HBV) Vaccine Market by Value
4.2.6 China Saccharomyces Cerevisiae Hepatitis B Virus (HBV) Vaccine Market by Value
4.3 EU+UK Hepatitis B Virus (HBV) Vaccine Market: An Analysis
4.3.1 EU+UK Hepatitis B Virus (HBV) Vaccine Market: An Overview
4.3.2 EU+UK Hepatitis B Virus (HBV) Vaccine Market by Value
4.3.3 EU+UK Hepatitis B Virus (HBV) Vaccine Market by Region (Italy, Germany, France, Spain, and The UK)
4.3.4 Italy Hepatitis B Virus (HBV) Vaccine Market by Value
4.3.5 Germany Hepatitis B Virus (HBV) Vaccine Market by Value
4.3.6 France Hepatitis B Virus (HBV) Vaccine Market by Value
4.3.7 Spain Hepatitis B Virus (HBV) Vaccine Market by Value
4.3.8 The UK Hepatitis B Virus (HBV) Vaccine Market by Value
4.3.9 EU+UK Hepatitis B Virus (HBV) Vaccine Market by Eligible Adults
4.3.10 EU+UK Hepatitis B Virus (HBV) Vaccine Market by Number of Patients Who Receive HBV Vaccine
4.4 Japan Hepatitis B Virus (HBV) Vaccine Market: An Analysis
4.4.1 Japan Hepatitis B Virus (HBV) Vaccine Market: An Overview
4.4.2 Japan Hepatitis B Virus (HBV) Vaccine Market by Value
4.5 Rest of World Hepatitis B Virus (HBV) Vaccine Market: An Analysis
4.5.1 Rest of World Hepatitis B Virus (HBV) Vaccine Market: An Overview
4.5.2 Rest of World Hepatitis B Virus (HBV) Vaccine Market by Value
5. Impact of COVID-19
5.1 Impact of COVID-19
5.1.1 Impact of COVID-19 on Healthcare
5.1.2 Impact of COVID-19 on HBV Vaccine Market
5.1.3 Post-COVID Scenario
6. Market Dynamics
6.1 Growth Drivers
6.1.1 Rapid Urbanization
6.1.2 Increasing Geriatric Population
6.1.3 Increasing Healthcare Expenditure
6.1.4 Growing Instances of HBV Among Infants
6.1.5 Increase in Liver Cancer and Cirrhosis Deaths due to HBV
6.1.6 Rising Prevalence of Hepatitis B Virus
6.2 Challenges
6.2.1 High Cost of Vaccine Development
6.2.2 Inequitable Access to Vaccines
6.3 Market Trends
6.3.1 Use of AI in Vaccine and Drug Design
6.3.2 Technological Advancements in Vaccine Administration
6.3.3 Favorable Government Initiatives and Policies
7. Competitive Landscape
7.1 The US HBV Vaccine Market Players: Vaccine Type Comparison
7.2 China Hepatitis B Virus (HBV) Vaccine Players by Market Share
8. Company Profiles
8.1 GlaxoSmithKline
8.1.1 Business Overview
8.1.2 Operating Segments
8.1.3 Business Strategies
8.2 Merck & Co., Inc.
8.2.1 Business Overview
8.2.2 Operating Segments
8.2.3 Business Strategies
8.3 Sanofi
8.3.1 Business Overview
8.3.2 Operating Segments
8.3.3 Business Strategies
8.4 Dynavax Technologies Corporation
8.4.1 Business Overview
8.4.2 Revenues by Product
8.4.3 Business Strategies
8.5 VBI Vaccines Inc.
8.5.1 Business Overview
8.5.2 Revenues from External Customers
8.5.3 Business Strategies
8.6 Meiji Group (KM Biologics)
8.6.1 Business Overview
8.6.2 Operating Segments
8.6.3 Business Strategies
8.7 Shenzhen Kangtai Biological Products Co., Ltd.
8.7.1 Business Overview
8.7.2 Operating Income by Products
8.7.3 Business Strategies
8.8 LG Chem Ltd.
8.8.1 Business Overview
8.8.2 Operating Segments
8.8.3 Business Strategies
8.9 Cyrus Poonawalla Group (Serum Institute of India Pvt. Ltd.)
8.9.1 Business Overview
8.9.2 Business Strategies
8.10 Indian Immunologicals Limited
8.10.1 Business Overview
8.10.2 Business Strategies
List of Figures
Figure 1: Common Symptoms of Hepatitis B Virus
Figure 2: Chronology & Type of Hepatitis B Vaccines Licensed for Use in the US
Figure 3: Indications for Hepatitis B Vaccination
Figure 4: Hepatitis B Virus Vaccine Segmentation
Figure 5: Global Hepatitis B Virus (HBV) Vaccine Market by Value; 2017-2021 (US$ Billion)
Figure 6: Global Hepatitis B Virus (HBV) Vaccine Market by Value; 2022-2027 (US$ Billion)
Figure 7: Global Hepatitis B Virus (HBV) Vaccine Market by End User; 2021 (Percentage, %)
Figure 8: Global Hepatitis B Virus (HBV) Vaccine Market by Region; 2021 (Percentage, %)
Figure 9: Global Adult Hepatitis B Virus Vaccine Market by Value; 2017-2021 (US$ Billion)
Figure 10: Global Adult Hepatitis B Virus Vaccine Market by Value; 2022-2027 (US$ Billion)
Figure 11: Global Adult Hepatitis B Virus Vaccine Market by Composition; 2021 (Percentage, %)
Figure 12: Global Pediatric Hepatitis B Virus Vaccine Market by Value; 2017-2021 (US$ Million)
Figure 13: Global Pediatric Hepatitis B Virus Vaccine Market by Value; 2022-2027 (US$ Billion)
Figure 14: Global Adult Mono Hepatitis B Virus (HBV) Vaccine Market by Value; 2017-2021 (US$ Million)
Figure 15: Global Adult Mono Hepatitis B Virus (HBV) Vaccine Market by Value; 2022-2027 (US$ Million)
Figure 16: Global Adult Combination Hepatitis B Virus (HBV) Vaccine Market by Value; 2017-2021 (US$ Million)
Figure 17: Global Adult Combination Hepatitis B Virus (HBV) Vaccine Market by Value; 2022-2027 (US$ Million)
Figure 18: The US Hepatitis B Virus (HBV) Vaccine Market by Value; 2017-2021 (US$ Million)
Figure 19: The US Hepatitis B Virus (HBV) Vaccine Market by Value; 2022-2027 (US$ Million)
Figure 20: The US Hepatitis B Virus (HBV) Vaccine Market by Eligible Adults; 2021-2027 (Million)
Figure 21: The US Hepatitis B Virus (HBV) Vaccine Market by Number of Patients Who Receive HBV Vaccine; 2021-2027 (Million)
Figure 22: China Hepatitis B Virus (HBV) Vaccine Market by Value; 2017-2021 (US$ Million)
Figure 23: China Hepatitis B Virus (HBV) Vaccine Market by Value; 2022-2027 (US$ Million)
Figure 24: China Hepatitis B Virus Vaccine Market by Composition; 2021 (Percentage, %)
Figure 25: China CHO Hepatitis B Virus (HBV) Vaccine Market by Value; 2017-2021 (US$ Million)
Figure 26: China CHO Hepatitis B Virus (HBV) Vaccine Market by Value; 2022-2027 (US$ Million)
Figure 27: China Hansenula Polymorpha Hepatitis B Virus (HBV) Vaccine Market by Value; 2017-2021 (US$ Million)
Figure 28: China Hansenula Polymorpha Hepatitis B Virus (HBV) Vaccine Market by Value; 2022-2027 (US$ Million)
Figure 29: China Saccharomyces Cerevisiae Hepatitis B Virus (HBV) Vaccine Market by Value; 2017-2021 (US$ Million)
Figure 30: China Saccharomyces Cerevisiae Hepatitis B Virus (HBV) Vaccine Market by Value; 2022-2027 (US$ Million)
Figure 31: EU+UK Hepatitis B Virus (HBV) Vaccine Market by Value; 2017-2021 (US$ Million)
Figure 32: EU+UK Hepatitis B Virus (HBV) Vaccine Market by Value; 2022-2027 (US$ Million)
Figure 33: EU+UK Hepatitis B Virus (HBV) Vaccine Market by Region; 2021 (Percentage)
Figure 34: Italy Hepatitis B Virus (HBV) Vaccine Market by Value; 2017-2021 (US$ Million)
Figure 35: Italy Hepatitis B Virus (HBV) Vaccine Market by Value; 2022-2027 (US$ Million)
Figure 36: Germany Hepatitis B Virus (HBV) Vaccine Market by Value; 2017-2021 (US$ Million)
Figure 37: Germany Hepatitis B Virus (HBV) Vaccine Market by Value; 2022-2027 (US$ Million)
Figure 38: France Hepatitis B Virus (HBV) Vaccine Market by Value; 2017-2021 (US$ Million)
Figure 39: France Hepatitis B Virus (HBV) Vaccine Market by Value; 2022-2027 (US$ Million)
Figure 40: Spain Hepatitis B Virus (HBV) Vaccine Market by Value; 2017-2021 (US$ Million)
Figure 41: Spain Hepatitis B Virus (HBV) Vaccine Market by Value; 2022-2027 (US$ Million)
Figure 42: The UK Hepatitis B Virus (HBV) Vaccine Market by Value; 2017-2021 (US$ Million)
Figure 43: The UK Hepatitis B Virus (HBV) Vaccine Market by Value; 2022-2027 (US$ Million)
Figure 44: EU+UK Hepatitis B Virus (HBV) Vaccine Market by Eligible Adults; 2021-2027 (Million)
Figure 45: EU+UK Hepatitis B Virus (HBV) Vaccine Market by Number of Patients Who Receive HBV Vaccine; 2021-2027 (Thousand)
Figure 46: Japan Hepatitis B Virus (HBV) Vaccine Market by Value; 2017-2021 (US$ Million)
Figure 47: Japan Hepatitis B Virus (HBV) Vaccine Market by Value; 2022-2027 (US$ Million)
Figure 48: Rest of World Hepatitis B Virus (HBV) Vaccine Market by Value; 2017-2021 (US$ Million)
Figure 49: Rest of World Hepatitis B Virus (HBV) Vaccine Market by Value; 2022-2027 (US$ Million)
Figure 50: Global Urban Population as a Share of Total Population; 2016-2022 (Percentage, %)
Figure 51: Global Population Aged 65+; 2016-2021 (Million)
Figure 52: The US Health Consumption Expenditure as a Percentage of GDP; 2016-2022 (Percentage, %)
Figure 53: Global Market Size for Artificial Intelligence in Healthcare; 2016-2025 (US $Billion)
Figure 54: China Hepatitis B Virus (HBV) Vaccine Players by Market Share; 2021 (Percentage, %)
Figure 55: GlaxoSmithKline Turnover by Segments; 2021 (Percentage, %)
Figure 56: Merck & Co., Inc. Sales by Segments; 2021 (Percentage, %)
Figure 57: Sanofi Net Sales by Segments; 2021 (Percentage, %)
Figure 58: Dynavax Technologies Corporation Revenues by Products; 2021 (Percentage, %)
Figure 59: VBI Vaccines Inc. Revenues from External Customers; 2021 (Percentage, %)
Figure 60: Meiji Group Net Sales by Segments; 2022 (Percentage, %)
Figure 61: Shenzhen Kangtai Biological Products Co., Ltd. Operating Income by Products; 2021 (Percentage, %)
Figure 62: LG Chem Ltd. Revenue by Segments; 2021 (Percentage,%)
Table 1: The US HBV Vaccine Market Players: Vaccine Type Comparison
